These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Subretinal hemorrhage after grid laser photocoagulation for idiopathic juxtafoveolar retinal telangiectasis. Friedman SM, Mames RN, Stewart MW. Ophthalmic Surg; 1993 Aug; 24(8):551-3. PubMed ID: 8233321 [Abstract] [Full Text] [Related]
34. Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II. Kovach JL, Rosenfeld PJ. Retina; 2009 Jan; 29(1):27-32. PubMed ID: 18936721 [Abstract] [Full Text] [Related]
35. A case of subretinal neovascularization treated with intravitreal ranibizumab in a patient with idiopathic juxtafoveal retinal telangiectasis. Karagiannis D, Georgalas I, Ladas I, Eustratios P, Mitropoulos P. Clin Interv Aging; 2009 Jan; 4():63-5. PubMed ID: 19503767 [Abstract] [Full Text] [Related]
37. Clinical features of idiopathic juxtafoveal telangiectasis in Koreans. Lee SW, Kim SM, Kim YT, Kang SW. Korean J Ophthalmol; 2011 Aug; 25(4):225-30. PubMed ID: 21860567 [Abstract] [Full Text] [Related]
39. Unfavorable effect of photodynamic therapy for late subretinal neovascularization with chorioretinal anastomoses associated with idiopathic multiple serous detachments of the retinal pigment epithelium. Fossarello M, Peiretti E, Zucca I, Serra A. Eur J Ophthalmol; 2004 Aug; 14(6):568-71. PubMed ID: 15638110 [Abstract] [Full Text] [Related]